[ad_1] MUNICH–(COMMERCIAL THREAD) –Xlife Sciences AG has successfully completed its 60% stake in the project company Araxa Biosciences GmbH in Veraxa Biotech AG (formerly Velaxa AG). This transaction has a total value of over 20 million euros and Xlife Sciences AG will now sit on the board of directors of Veraxa as a minority shareholder. […]
